Mostrar el registro sencillo del ítem
Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia
dc.contributor.author | Dedet, JP | |
dc.contributor.author | Melogno, R | |
dc.contributor.author | Cárdenas, F | |
dc.contributor.author | Valda, L | |
dc.contributor.author | David, C | |
dc.contributor.author | Fernández, V | |
dc.contributor.author | Torrez, ME | |
dc.contributor.author | Dimier-David, L | |
dc.contributor.author | Lyevre, P | |
dc.contributor.author | Villareal, ME | |
dc.date.accessioned | 2017-10-16T15:53:41Z | |
dc.date.available | 2017-10-16T15:53:41Z | |
dc.date.issued | 1995 | |
dc.identifier.uri | http://repositorio.umsa.bo/xmlui/handle/123456789/12839 | |
dc.description.abstract | Abstract. Mucocutaneous leishmaniasis (MCL) is endemic in the tropical Amazonian lowlands of Bolivia, an area that regularly receives influxes of migratory populations. In these new agricultural development areas, a campaign to diagnose and treat the disease was carried out between 1989 and 1992, in order to provide direct access to MCL treatment in the endemic areas at a standard equivalent to that offered in the urban centres in Bolivia. The campaign led to the creation of decentralized local centres for diagnosis and treatment of the disease. A campaign to inform the population about leishmaniasis was also undertaken and courses were run to educate medical and paramedical personnel. As a result of the campaign, 3285 cases of leishmaniasis were diagnosed, including 2152 cutaneous and 326 mucosal forms. Also, a total of 1888 cases were treated, 1677 of which cutaneous and 211, mucosal. | es_ES |
dc.language.iso | en | es_ES |
dc.publisher | Bulletin of the World Health Organization | es_ES |
dc.subject | CAMPAÑA RURAL | es_ES |
dc.subject | DIAGNÓSTICO Y TRATAMIENTO | es_ES |
dc.subject | LEISHMANIASIS MUCOCUTÁNEA | es_ES |
dc.subject | BOLIVIA | es_ES |
dc.title | Rural campaign to diagnose and treat mucocutaneous leishmaniasis in Bolivia | es_ES |
dc.type | Article | es_ES |